T h e s e r u m s p e c I a L i s t Since fbs is initially a non-uti
Yüklə 29,84 Kb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- Moving Forward
- TOPICS FOR DISCUSSION AND ANALYSIS
- O L E BO DT K E R N I E L S E N
| 6 T h e S e r u m S p e c i a l i s t Since FBS is initially a non-uti- lized byproduct available from slaughterhouses worldwide, the global supply of FBS has perma- nently exceeded global demand. Today, conditions are favorable for uniform and stable purcha- sing and sale prices at more af- fordable levels. The problem has been barriers to trade and the lack of scientific information to FBS users. This has generated a fragmentation of the serum world, with different supply/de- mand constellations in different segments, and price differences between origins sometimes ex- ceeding 1,000%. If FBS is dealt with in a transpa- rent, customer-friendly, scien- tifically-correct way and trade barriers and misinformation are eliminated, FBS will be more abundant and less expensive, and there will be no economic incentives for criminal activi- ties. This is how it should be. Instead, historically, the serum industry has occasionally in- terrupted collection, creating shortages; objected to opening imports of FBS into the USA from South America as pro- posed twice by the USDA; and misinformed serum users and regulators about the safety of Future,
AS LONG AS IMPORT RULES ARE DIFFERENT BETWEEN COUNTRIES, AND RESULTING SERUM PRICES VARY BY UP TO A FACTOR OF 10, TRACEABILITY-RELATED CRIMES CAN OCCUR. ILLEGAL ACTIVITIES MUST BE STOPPED BECAUSE THEY NOT ONLY NEGATIVELY AFFECT SERUM USERS AND THE IMAGE OF THE SERUM INDUSTRY, BUT THE LONG TERM VIABILITY OF FBS AS A PRODUCT. ISIA MUST INTENSIFY EFFORTS TO EDUCATE AND TO PROMOTE THE HARMONIZATION OF INTERNATIONAL IMPORT RULES.
FETAL BOVINE SERUM HANDOUT TOPICS FOR DISCUSSION AND ANALYSIS 7 different sources. The concept that Oceania is safer is still part of some marketing campaigns, even after BSE has been found to be a spontaneous event in all cattle populations (Nobel Prize winner Stanley Pruziner), and it has been determined by OIE
products. The latest case of FBS fraud, as uncovered by the French autho- rities, was elaborate and had a low risk of being detected. It was discovered by pure chance and may have continued indefini- tely under slightly different cir- cumstances, like the PAA case. This type of activity can only be eradicated by eliminating eco- nomic incentives, via science, education, and harmonization. The damage done to researchers and other serum users includes inexact or invalidated results in research and diagnostics, virus risks, product recalls, etc. From a financial viewpoint, losses include costs of lost research,
FBS prices actually paid and the much lower prices that should have been paid for the same product if it had been justly declared. The damage to competitors consists of lost FBS business and the cross-effects on sales of media, reagents, plastics, and equipment. The vast majority of serum companies have always worked legally, taking traceability com- pliance seriously and control- ling their supply chain. With the traceability laws that have been implemented by the EU and other countries, as well as the new ownership of compa- nies historically associated with questionable practices, illegal schemes are no longer likely to happen. Today, all serum com- panies adhere to strict codes of ethics. However, the risk of misrepresentation still exists in cases where the product goes through a chain of intermedia- ries. To eliminate potential ille- gal activities, economic incen- tives must be attacked at the root, by the harmonization of import rules and the education of serum users and regulators, based on science. F ut ur e , M o v in g F o rw a rd NOTE
..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... ..................................................................... AU T H O R : O L E BO DT K E R N I E L S E N , C EO - B I OW EST T H E S E RU M S P EC I A L I ST
BIOWEST S.A.S. rue de la caille - 49340 Nuaillé FRANCE Tél. : (+33) 241 464 242 Fax : (+33) 241 464 050 Email : biowest@biowest.net www.biowest.net T h e S e r u m S p e c i a l i s t RC S
ge rs 4 34 12
1 8 36 - Té l.
02 4 1 7 0 05 12 - © P ho to
sc Yüklə 29,84 Kb. Dostları ilə paylaş:
|